Attenuation imaging for hepatic steatosis in chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease

doi:10.3748/wjg.v31.i11.102795

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (713)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-4) series.

Item

Count

PDF

HTML

417

Figures (1-6)

Tables (1-4)

Sum=614

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=65

Mar 21, 2025 (publication date) through Apr 6, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Mar 21, 2025; 31(11): 102795
Published online Mar 21, 2025. doi: 10.3748/wjg.v31.i11.102795

Full Size Figure Download Figure

Figure 4 Box plot graphs illustrating the distribution of attenuation coefficient with different fibrosis stages within each steatosis grade. A: Liver steatosis grade S0; B: Liver steatosis grade S1; C: Liver steatosis grade S2; D: Liver steatosis grade S3. Boxes represent the 25^th and 75^th percentiles and outlier dots.

Citation: Li XQ, Cheng GW, Akiyama I, Huang XJ, Liang J, Xue LY, Cheng Y, Kudo M, Ding H. Attenuation imaging for hepatic steatosis in chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2025; 31(11): 102795
URL: https://www.wjgnet.com/1007-9327/full/v31/i11/102795.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i11.102795